National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
 
 
Results: 1 -10 of 361         results per page
View Search Criteria | Help With Results
Title 
Phase sort descending
Protocol IDs 
 
Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy

   
Phase IV

   
EPI-GLIO-LEV
NCT00454935

 
 
Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery

   
Phase IV

   
HELLO-Study 2007
EudraCT Number: 2007-005063-96, NCT00571155

 
 
Contrast Enhanced Magnetic Resonance Imaging (MRI) of the Central Nervous System (CNS) - Patients With Known Cerebral Neoplastic Lesions

   
Phase IV

   
91780
EudraCT 2007-005693-31, 312021, NCT00764387

 
 
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer

   
Phase III, Phase II

   
SP-11-0035
NCT00123760

 
 
Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma

   
Phase III

   
MRC-BR12
EU-20114, ISRCTN83176944, NCT00052455

 
 
Human Corticotropin-Releasing Factor in Controlling Symptoms Associated With Brain Swelling in Patients With Malignant Brain Tumors

   
Phase III

   
NTI-0303
BCM-H-14962, NCT00088166

 
 
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer

   
Phase III

   
RTOG-0320
NCT00096265

 
 
A Trial Comparing Radiosurgery With Surgery for Solitary Brain Metastases

   
Phase III

   
021108
NCT00124761

 
 
Radiation Therapy or Temozolomide in Treating Patients With Gliomas

   
Phase III

   
EORTC-22033
EORTC-26033, EudraCT-2004-002714-11, CAN-NCIC-CE5, NCT00182819, TROG 06.01, CE5

 
 
18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology

   
Phase III

   
R05-0076
NCT00207298

 
      1 2 3 4   Next >

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov